Partnership
Three major capital ventures already trust in LUMILOG:
"LUMILOG has gained exclusive world-wide rights to a breakthrough
technology of production of very high quality GaN substrates."
"A National Scientific Research Institute spin-off, LUMILOG has the
ambition to become the world leader on the GaN substrates market.
That’s why EMERTEC GESTION has decided to follow LUMILOG."
"SOPHIA EUROLABS invests in projects whose technology is proven
but whose market entry needs support. This was typically the case
with LUMILOG."
CRHEA-CNRS also holds shares in the capital of LUMILOG as a result of
transfer of intellectual property.
